$ANGO
ANGIODYNAMICS INC

2021 Form 10-K Financial Statement

#000127518721000013 Filed on July 27, 2021

View on sec.gov

Income Statement

Concept 2021 2020 Q2 2020
Revenue $291.0M $58.33M $264.2M
YoY Change 10.17% -18.05% -2.39%
Cost Of Revenue $134.2M $28.12M $113.9M
YoY Change 17.86% -5.8% -0.65%
Gross Profit $156.8M $30.21M $150.3M
YoY Change 4.34% -26.9% -3.67%
Gross Profit Margin 53.88% 51.79% 56.89%
Selling, General & Admin $117.2M $26.43M $116.5M
YoY Change 0.62% -9.67% 4.27%
% of Gross Profit 74.77% 87.48% 77.53%
Research & Development $36.39M $7.230M $29.68M
YoY Change 22.6% 4.93% 5.04%
% of Gross Profit 23.21% 23.93% 19.75%
Depreciation & Amortization $5.700M $6.260M $3.300M
YoY Change 72.73% -6.85% 6.45%
% of Gross Profit 3.64% 20.72% 2.2%
Operating Expenses $192.1M $26.71M $317.4M
YoY Change -39.48% -18.99% 91.88%
Operating Profit -$35.28M $3.502M -$167.1M
YoY Change -78.88% -58.12% 1678.4%
Interest Expense $861.0K -$240.0K $907.0K
YoY Change -5.07% -82.98% -82.21%
% of Operating Profit -6.85%
Other Income/Expense, Net $92.00K -$60.00K -$130.0K
YoY Change -170.77% -57.14% -37.2%
Pretax Income -$36.05M -$156.9M -$168.1M
YoY Change -78.56% -11388.49% 978.27%
Income Tax -$4.504M $160.0K -$1.348M
% Of Pretax Income
Net Earnings -$31.55M -$157.1M -$166.8M
YoY Change -81.08% -366.79% -371.91%
Net Earnings / Revenue -10.84% -269.26% -63.14%
Basic Earnings Per Share -$0.82 -$4.14 -$4.39
Diluted Earnings Per Share -$0.82 -$4.14 -$4.39
COMMON SHARES
Basic Shares Outstanding 38.34M shares 37.69M shares 37.96M shares
Diluted Shares Outstanding 38.34M shares 37.96M shares

Balance Sheet

Concept 2021 2020 Q2 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.96M $54.40M $54.40M
YoY Change -6.33% -76.1% -76.1%
Cash & Equivalents $48.16M $54.44M $54.40M
Short-Term Investments $2.795M
Other Short-Term Assets $5.902M $7.300M $4.400M
YoY Change 34.14% 82.5% 10.0%
Inventory $48.61M $59.91M $59.90M
Prepaid Expenses
Receivables $35.41M $31.26M $31.30M
Other Receivables $2.000K $0.00 $2.900M
Total Short-Term Assets $140.9M $152.9M $152.9M
YoY Change -7.86% -51.5% -51.51%
LONG-TERM ASSETS
Property, Plant & Equipment $46.46M $28.31M $38.50M
YoY Change 20.66% 16.71% 58.44%
Goodwill $200.5M
YoY Change -42.33%
Intangibles $197.1M
YoY Change 35.59%
Long-Term Investments
YoY Change
Other Assets $3.811M $15.34M $5.200M
YoY Change -26.71% 299.95% 36.84%
Total Long-Term Assets $420.6M $441.3M $441.3M
YoY Change -4.7% -15.32% -15.31%
TOTAL ASSETS
Total Short-Term Assets $140.9M $152.9M $152.9M
Total Long-Term Assets $420.6M $441.3M $441.3M
Total Assets $561.4M $594.2M $594.2M
YoY Change -5.51% -28.96% -28.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $19.63M $19.10M $19.10M
YoY Change 2.77% -16.35% -16.23%
Accrued Expenses $37.87M $29.38M $31.50M
YoY Change 20.23% -23.37% -17.75%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $57.58M $51.45M $51.40M
YoY Change 12.03% -29.82% -29.88%
LONG-TERM LIABILITIES
Long-Term Debt $20.00M $40.00M $40.00M
YoY Change -50.0% -67.85% -67.85%
Other Long-Term Liabilities $24.44M $9.029M $23.80M
YoY Change 2.7% 1633.01% 153.19%
Total Long-Term Liabilities $44.44M $9.029M $63.80M
YoY Change -30.34% -92.77% -52.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $57.58M $51.45M $51.40M
Total Long-Term Liabilities $44.44M $9.029M $63.80M
Total Liabilities $122.0M $139.3M $139.3M
YoY Change -12.43% -37.13% -37.14%
SHAREHOLDERS EQUITY
Retained Earnings -$100.3M
YoY Change -250.92%
Common Stock $562.2M
YoY Change 1.23%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.714M
YoY Change 0.0%
Treasury Stock Shares 370.0M shares
Shareholders Equity $439.5M $454.9M $454.9M
YoY Change
Total Liabilities & Shareholders Equity $561.4M $594.2M $594.2M
YoY Change -5.51% -28.96% -28.96%

Cashflow Statement

Concept 2021 2020 Q2 2020
OPERATING ACTIVITIES
Net Income -$31.55M -$157.1M -$166.8M
YoY Change -81.08% -366.79% -371.91%
Depreciation, Depletion And Amortization $5.700M $6.260M $3.300M
YoY Change 72.73% -6.85% 6.45%
Cash From Operating Activities $24.09M $3.880M -$14.55M
YoY Change -265.54% -84.49% -138.87%
INVESTING ACTIVITIES
Capital Expenditures $5.187M -$1.480M $7.235M
YoY Change -28.31% 80.49% 132.04%
Acquisitions
YoY Change
Other Investing Activities -$8.524M $0.00 -$55.76M
YoY Change -84.71% -100.0% -165.09%
Cash From Investing Activities -$13.71M -$1.480M -$63.35M
YoY Change -78.36% -100.88% -176.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $20.00M $132.5M
YoY Change -84.91% 783.33%
Cash From Financing Activities -$16.99M 24.95M -$95.24M
YoY Change -82.17% -444.61% -380.69%
NET CHANGE
Cash From Operating Activities $24.09M 3.880M -$14.55M
Cash From Investing Activities -$13.71M -1.480M -$63.35M
Cash From Financing Activities -$16.99M 24.95M -$95.24M
Net Change In Cash -$6.274M 27.35M -$173.2M
YoY Change -96.38% -85.31% -212.8%
FREE CASH FLOW
Cash From Operating Activities $24.09M $3.880M -$14.55M
Capital Expenditures $5.187M -$1.480M $7.235M
Free Cash Flow $18.91M $5.360M -$21.79M
YoY Change -186.77% -79.25% -163.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001275187
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201602Member
CY2021Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssets
CY2020Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssets
CY2021Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2020Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2020Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2021Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-05-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
0-50761
CY2021 dei Entity Registrant Name
EntityRegistrantName
AngioDynamics, Inc.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
11-3146460
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
14 Plaza Drive
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Latham
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
12110
CY2021 dei City Area Code
CityAreaCode
518
CY2021 dei Local Phone Number
LocalPhoneNumber
795-1400
CY2021 dei Security12b Title
Security12bTitle
Common Stock, par value $.01 per share
CY2021 dei Trading Symbol
TradingSymbol
ANGO
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Public Float
EntityPublicFloat
496277118 USD
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38444076 shares
CY2021 us-gaap Revenues
Revenues
291010000 USD
CY2020 us-gaap Revenues
Revenues
264157000 USD
CY2019 us-gaap Revenues
Revenues
270634000 USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
134222000 USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
113885000 USD
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
114634000 USD
CY2021 us-gaap Gross Profit
GrossProfit
156788000 USD
CY2020 us-gaap Gross Profit
GrossProfit
150272000 USD
CY2019 us-gaap Gross Profit
GrossProfit
156000000 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36390000 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29682000 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28258000 USD
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
81306000 USD
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
78634000 USD
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
76829000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35918000 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37872000 USD
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34902000 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18136000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18121000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17056000 USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
158578000 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021 ango Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
89000 USD
CY2020 ango Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-11531000 USD
CY2019 ango Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-6776000 USD
CY2021 ango Acquisition Restructuring And Other Items Net
AcquisitionRestructuringAndOtherItemsNet
20232000 USD
CY2020 ango Acquisition Restructuring And Other Items Net
AcquisitionRestructuringAndOtherItemsNet
6014000 USD
CY2019 ango Acquisition Restructuring And Other Items Net
AcquisitionRestructuringAndOtherItemsNet
15127000 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
192071000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
317370000 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
165396000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-35283000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-167098000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-9396000 USD
CY2019 us-gaap Interest Expense
InterestExpense
5099000 USD
CY2021 us-gaap Interest Expense
InterestExpense
861000 USD
CY2020 us-gaap Interest Expense
InterestExpense
907000 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
92000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-130000 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-207000 USD
CY2021 ango Other Nonoperating Income Expense And Interest Expense
OtherNonoperatingIncomeExpenseAndInterestExpense
-769000 USD
CY2020 ango Other Nonoperating Income Expense And Interest Expense
OtherNonoperatingIncomeExpenseAndInterestExpense
-1037000 USD
CY2019 ango Other Nonoperating Income Expense And Interest Expense
OtherNonoperatingIncomeExpenseAndInterestExpense
-5306000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-36052000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-168135000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-14702000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4504000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1348000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3556000 USD
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-31548000 USD
CY2020 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-166787000 USD
CY2019 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-11146000 USD
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
CY2019 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
72486000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-31548000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-166787000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-166787000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-166787000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
61340000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
61340000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
61340000 USD
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.82
CY2020 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-4.39
CY2019 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.30
CY2021 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.82
CY2020 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-4.39
CY2019 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.30
CY2021 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0
CY2020 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0
CY2019 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
1.93
CY2021 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0
CY2020 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0
CY2019 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
1.93
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.82
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.39
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.64
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.82
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.39
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.64
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38342000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37961000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37485000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38342000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37961000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37485000 shares
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-31548000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-166787000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-166787000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-166787000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
61340000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
61340000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
61340000 USD
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
0 USD
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
0 USD
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
33000 USD
CY2021 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0 USD
CY2020 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0 USD
CY2019 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
116000 USD
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
4494000 USD
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
11000 USD
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-317000 USD
CY2021 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
4494000 USD
CY2020 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
11000 USD
CY2019 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-400000 USD
CY2021 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0 USD
CY2020 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0 USD
CY2019 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4494000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-400000 USD
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27054000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-166776000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
60940000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48161000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54435000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1919000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2150000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
35405000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31263000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
48614000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
59905000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8699000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7310000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
140879000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
152913000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37073000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28312000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
168977000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
197136000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
201316000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
200515000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13193000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15338000 USD
CY2021Q2 us-gaap Assets
Assets
561438000 USD
CY2020Q2 us-gaap Assets
Assets
594214000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
19630000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
19096000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
35459000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29380000 USD
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 USD
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
836000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2495000 USD
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2133000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
57584000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
51445000 USD
CY2021Q2 us-gaap Loans Payable
LoansPayable
20000000 USD
CY2020Q2 us-gaap Loans Payable
LoansPayable
40000000 USD
CY2021Q2 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
19955000 USD
CY2020Q2 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
24057000 USD
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
15741000 USD
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
14811000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8701000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9029000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
121981000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
139342000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38920951 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38448536 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38550951 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38078536 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
377000 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
374000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
573507000 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
561871000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-131866000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-100318000 USD
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
370000000 shares
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
370000000 shares
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
5714000 USD
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
5714000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3153000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1341000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
439457000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
454872000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
561438000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
594214000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
542595000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
61340000 USD
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1526000 USD
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1172000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9249000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-400000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
614815000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-166787000 USD
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
561000 USD
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1217000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7592000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
454872000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-31548000 USD
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1930000 USD
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1307000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8625000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4494000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
439457000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-31548000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-166787000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-166787000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-166787000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
61340000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
61340000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
61340000 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
25916000 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
23805000 USD
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
25880000 USD
CY2021 ango Noncash Lease Expense
NoncashLeaseExpense
2456000 USD
CY2020 ango Noncash Lease Expense
NoncashLeaseExpense
2070000 USD
CY2019 ango Noncash Lease Expense
NoncashLeaseExpense
0 USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
158578000 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
8625000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
7592000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
9249000 USD
CY2021 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2020 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2019 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
46592000 USD
CY2021 ango Transaction Costs Disposition
TransactionCostsDisposition
0 USD
CY2020 ango Transaction Costs Disposition
TransactionCostsDisposition
0 USD
CY2019 ango Transaction Costs Disposition
TransactionCostsDisposition
-4030000 USD
CY2021 ango Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
89000 USD
CY2020 ango Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-11531000 USD
CY2019 ango Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-6776000 USD
CY2021 ango Deferred Income Tax Related To Operating Activity
DeferredIncomeTaxRelatedToOperatingActivity
-4805000 USD
CY2020 ango Deferred Income Tax Related To Operating Activity
DeferredIncomeTaxRelatedToOperatingActivity
-1568000 USD
CY2019 ango Deferred Income Tax Related To Operating Activity
DeferredIncomeTaxRelatedToOperatingActivity
-2655000 USD
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
207000 USD
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
429000 USD
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-202000 USD
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
14228000 USD
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1321000 USD
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2495000 USD
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
147000 USD
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-86000 USD
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
5000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4162000 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11918000 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3177000 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-11539000 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
18845000 USD
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1428000 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3181000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6155000 USD
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1871000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4876000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-15467000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5212000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24093000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14554000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
37440000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5187000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7235000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3118000 USD
CY2021 ango Increase In Placement And Evaluation Units
IncreaseInPlacementAndEvaluationUnits
8524000 USD
CY2020 ango Increase In Placement And Evaluation Units
IncreaseInPlacementAndEvaluationUnits
0 USD
CY2019 ango Increase In Placement And Evaluation Units
IncreaseInPlacementAndEvaluationUnits
0 USD
CY2021 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
CY2020 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
CY2019 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
169242000 USD
CY2021 us-gaap Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
0 USD
CY2020 us-gaap Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
55760000 USD
CY2019 us-gaap Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
84920000 USD
CY2021 ango Payments To Acquire Intangible Assets Net Of Cash Acquired
PaymentsToAcquireIntangibleAssetsNetOfCashAcquired
0 USD
CY2020 ango Payments To Acquire Intangible Assets Net Of Cash Acquired
PaymentsToAcquireIntangibleAssetsNetOfCashAcquired
350000 USD
CY2019 ango Payments To Acquire Intangible Assets Net Of Cash Acquired
PaymentsToAcquireIntangibleAssetsNetOfCashAcquired
0 USD
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 USD
CY2020 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 USD
CY2019 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1350000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13711000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-63345000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
82554000 USD
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
20000000 USD
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
132500000 USD
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
15000000 USD
CY2021 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
CY2020 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
40000000 USD
CY2019 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
55000000 USD
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
775000 USD
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2020 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1208000 USD
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-8100000 USD
CY2021 ango Proceeds Payments Issuance Of Shares Share Based Payment Arrangement Including Option Exercised
ProceedsPaymentsIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised
3014000 USD
CY2020 ango Proceeds Payments Issuance Of Shares Share Based Payment Arrangement Including Option Exercised
ProceedsPaymentsIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised
-759000 USD
CY2019 ango Proceeds Payments Issuance Of Shares Share Based Payment Arrangement Including Option Exercised
ProceedsPaymentsIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised
2031000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16986000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-95242000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33931000 USD
CY2021 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
330000 USD
CY2020 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-65000 USD
CY2019 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-380000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6274000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-173206000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
153545000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54435000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227641000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74096000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48161000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54435000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227641000 USD
CY2021 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
-139000 USD
CY2020 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
224000 USD
CY2019 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
-114000 USD
CY2021 ango Noncashor Part Noncash Acquisition Valueof Contingent Consideration Received
NoncashorPartNoncashAcquisitionValueofContingentConsiderationReceived
0 USD
CY2020 ango Noncashor Part Noncash Acquisition Valueof Contingent Consideration Received
NoncashorPartNoncashAcquisitionValueofContingentConsiderationReceived
14900000 USD
CY2019 ango Noncashor Part Noncash Acquisition Valueof Contingent Consideration Received
NoncashorPartNoncashAcquisitionValueofContingentConsiderationReceived
25100000 USD
CY2021 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 USD
CY2020 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 USD
CY2019 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
4650000 USD
CY2021 us-gaap Interest Paid
InterestPaid
731000 USD
CY2020 us-gaap Interest Paid
InterestPaid
413000 USD
CY2019 us-gaap Interest Paid
InterestPaid
5115000 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
313000 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
682000 USD
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
426000 USD
CY2021 ango Short Term Investments Maturity Period
ShortTermInvestmentsMaturityPeriod
less than three months
CY2021 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 segment
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021 us-gaap Revenues
Revenues
291010000 USD
CY2020 us-gaap Revenues
Revenues
264157000 USD
CY2019 us-gaap Revenues
Revenues
270634000 USD
CY2021 ango Contractwith Customer Rightof Return Product Return Period After Purchase Date Requiring Pre Approval
ContractwithCustomerRightofReturnProductReturnPeriodAfterPurchaseDateRequiringPreApproval
P30D
CY2021 ango Contractwith Customer Rightof Return Restocking Charge
ContractwithCustomerRightofReturnRestockingCharge
0.20
CY2021 ango Contractwith Customer Rightof Return Minimum Remaining Product Life Priorto Return
ContractwithCustomerRightofReturnMinimumRemainingProductLifePriortoReturn
P12M
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
35405000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31263000 USD
CY2021Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2020Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
426000 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
545000 USD
CY2021 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
1000000.0 USD
CY2020 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
2100000 USD
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1200000 USD
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2200000 USD
CY2020Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
15647000 USD
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
89000 USD
CY2021 ango Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Currency Gain Loss From Remeasurement
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCurrencyGainLossFromRemeasurement
5000 USD
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
15741000 USD
CY2019Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
13486000 USD
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
14900000 USD
CY2020 ango Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-11531000 USD
CY2020 ango Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Contingent Consideration Liabilities Payments
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetContingentConsiderationLiabilitiesPayments
1208000 USD
CY2020Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
15647000 USD
CY2020Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
158600000 USD
CY2021Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
22925000 USD
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
23308000 USD
CY2021Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
8022000 USD
CY2020Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
8318000 USD
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
17667000 USD
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
28279000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
48614000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
59905000 USD
CY2021Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3800000 USD
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4700000 USD
CY2021Q2 ango Prepaid Deposits
PrepaidDeposits
2795000 USD
CY2020Q2 ango Prepaid Deposits
PrepaidDeposits
689000 USD
CY2021Q2 ango Prepaid Employee Tax Credit
PrepaidEmployeeTaxCredit
1911000 USD
CY2020Q2 ango Prepaid Employee Tax Credit
PrepaidEmployeeTaxCredit
0 USD
CY2021Q2 ango Software Licenses
SoftwareLicenses
1286000 USD
CY2020Q2 ango Software Licenses
SoftwareLicenses
1002000 USD
CY2021Q2 ango Tsa Receivable
TSAReceivable
2000 USD
CY2020Q2 ango Tsa Receivable
TSAReceivable
2911000 USD
CY2021Q2 ango Prepaid Licensee Fees
PrepaidLicenseeFees
166000 USD
CY2020Q2 ango Prepaid Licensee Fees
PrepaidLicenseeFees
203000 USD
CY2021Q2 ango Trade Shows
TradeShows
132000 USD
CY2020Q2 ango Trade Shows
TradeShows
296000 USD
CY2021Q2 us-gaap Prepaid Rent
PrepaidRent
268000 USD
CY2020Q2 us-gaap Prepaid Rent
PrepaidRent
246000 USD
CY2021Q2 ango Prepaid Incomeand Other Taxes
PrepaidIncomeandOtherTaxes
379000 USD
CY2020Q2 ango Prepaid Incomeand Other Taxes
PrepaidIncomeandOtherTaxes
414000 USD
CY2021Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1760000 USD
CY2020Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1549000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8699000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7310000 USD
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
82236000 USD
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
68501000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
45635000 USD
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
40661000 USD
CY2021Q2 ango Property Plant And Equipment Excluding Land And Land Improvements
PropertyPlantAndEquipmentExcludingLandAndLandImprovements
36601000 USD
CY2020Q2 ango Property Plant And Equipment Excluding Land And Land Improvements
PropertyPlantAndEquipmentExcludingLandAndLandImprovements
27840000 USD
CY2021Q2 us-gaap Land And Land Improvements
LandAndLandImprovements
472000 USD
CY2020Q2 us-gaap Land And Land Improvements
LandAndLandImprovements
472000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37073000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28312000 USD
CY2021 us-gaap Depreciation
Depreciation
5700000 USD
CY2020 us-gaap Depreciation
Depreciation
3300000 USD
CY2019 us-gaap Depreciation
Depreciation
3100000 USD
CY2021 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 segment
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2020Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
158600000 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18100000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18100000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17100000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
313235000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
144258000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
168977000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
327966000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
130830000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
197136000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
15156000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
15595000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
14111000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
15131000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
16138000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
92846000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
168977000 USD
CY2021Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
73000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-31595000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-166984000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-15593000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-4457000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1151000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
891000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-36052000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-168135000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-14702000 USD
CY2020Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1071000 USD
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
3091000 USD
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
1927000 USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
100000 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
96000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
128000 USD
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
201000 USD
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
124000 USD
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
289000 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
301000 USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
220000 USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
417000 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3375000 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1122000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3948000 USD
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-1430000 USD
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-446000 USD
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-25000 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4805000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1568000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3973000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4504000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1348000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3556000 USD
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
31564000 USD
CY2020Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
26697000 USD
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3556000 USD
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2923000 USD
CY2021Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6715000 USD
CY2020Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
5412000 USD
CY2021Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
884000 USD
CY2020Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
95000 USD
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
45883000 USD
CY2020Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
38125000 USD
CY2021Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
48744000 USD
CY2020Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
49023000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
48744000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
49023000 USD
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17035000 USD
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13114000 USD
CY2021Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
19896000 USD
CY2020Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
24012000 USD
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7571000 USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-35308000 USD
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3087000 USD
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-462000 USD
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-40000 USD
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-177000 USD
CY2021 ango Income Tax Reconciliation Effect Of Foreign Operations
IncomeTaxReconciliationEffectOfForeignOperations
-293000 USD
CY2020 ango Income Tax Reconciliation Effect Of Foreign Operations
IncomeTaxReconciliationEffectOfForeignOperations
-100000 USD
CY2019 ango Income Tax Reconciliation Effect Of Foreign Operations
IncomeTaxReconciliationEffectOfForeignOperations
76000 USD
CY2021 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1303000 USD
CY2020 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1152000 USD
CY2019 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
936000 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
116000 USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
171000 USD
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
190000 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
0 USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
33301000 USD
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
0 USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3921000 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1426000 USD
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
175000 USD
CY2021 ango Income Tax Reconciliation Effectof Eliminationof Asc718 Apic Pool
IncomeTaxReconciliationEffectofEliminationofASC718APICPool
-526000 USD
CY2020 ango Income Tax Reconciliation Effectof Eliminationof Asc718 Apic Pool
IncomeTaxReconciliationEffectofEliminationofASC718APICPool
-162000 USD
CY2019 ango Income Tax Reconciliation Effectof Eliminationof Asc718 Apic Pool
IncomeTaxReconciliationEffectofEliminationofASC718APICPool
0 USD
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
562000 USD
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
192000 USD
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
203000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4504000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1348000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3556000 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
158600000 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
464000 USD
CY2019Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
464000 USD
CY2018Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
464000 USD
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0 USD
CY2020 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0 USD
CY2019 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
464000 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
464000 USD
CY2019Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
464000 USD
CY2021Q2 us-gaap Increase In Unrecognized Tax Benefits Is Reasonably Possible
IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
500000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
20408000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13059000 USD
CY2021Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
4256000 USD
CY2020Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
2222000 USD
CY2021Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2663000 USD
CY2020Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2392000 USD
CY2021Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
548000 USD
CY2020Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
794000 USD
CY2021Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
631000 USD
CY2020Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
634000 USD
CY2021Q2 ango Accrued Litigation
AccruedLitigation
975000 USD
CY2020Q2 ango Accrued Litigation
AccruedLitigation
0 USD
CY2021Q2 ango Accrued Recall Liability
AccruedRecallLiability
0 USD
CY2020Q2 ango Accrued Recall Liability
AccruedRecallLiability
5000000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5978000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5279000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
35459000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29380000 USD
CY2021Q2 us-gaap Loans Payable
LoansPayable
20000000.0 USD
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3800000 USD
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3200000 USD
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3600000 USD
CY2014Q4 ango Capital Stock Shares Authorized
CapitalStockSharesAuthorized
80000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 ango Common Stock Votes Per Share
CommonStockVotesPerShare
1
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1938753 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.89
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
528809 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.41
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
137237 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
16.45
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
132895 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
18.38
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
50470 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
12.33
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2146960 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.59
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M26D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
16176000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1067686 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
16.26
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y10M28D
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
7324000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1079274 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
14.92
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y6M10D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
8852000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.97
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.46
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.53
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0034
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0163
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0278
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.39
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.31
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.31
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y11M15D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y10M28D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y9M14D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
800000 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
500000 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1400000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3900000 USD
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1900000 USD
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
600000 USD
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1500000 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
20.35
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
20.87
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8625000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7592000 USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9249000 USD
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2000000.0 USD
CY2020 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1700000 USD
CY2019 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2100000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
7.95
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37484573 shares
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.042
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
12.11
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
16.08
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38342476 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37961224 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37484573 shares
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38342476 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37961224 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3285354 shares
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2581006 shares
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2200318 shares
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9382000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10146000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2415000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2077000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7319000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8345000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
9734000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
10422000 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M13D
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2735000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2787000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2209000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1454000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1148000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
171000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10504000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
770000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
9734000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2415000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7319000 USD
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
3200000 USD
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
3400000 USD
CY2019 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2500000 USD
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
3207000 USD
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
3351000 USD
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
2698000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
2372000 USD
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1585000 USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6918000 USD
CY2021Q2 us-gaap Purchase Obligation
PurchaseObligation
4697000 USD
CY2021Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
4697000 USD
CY2021Q2 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
0 USD
CY2021Q2 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
0 USD
CY2021Q2 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
0 USD
CY2021Q2 ango Purchase Obligation To Be Paid After Year Four
PurchaseObligationToBePaidAfterYearFour
0 USD
CY2021Q2 ango Royalties
Royalties
47700000 USD
CY2021Q2 ango Royalties Due In First Year
RoyaltiesDueInFirstYear
3800000 USD
CY2021Q2 ango Royalties Duein Second Year
RoyaltiesDueinSecondYear
3800000 USD
CY2021Q2 ango Royalties Duein Third Year
RoyaltiesDueinThirdYear
3800000 USD
CY2021Q2 ango Royalties Duein Fourth Year
RoyaltiesDueinFourthYear
3800000 USD
CY2021Q2 ango Royalties Due After Fourth Year
RoyaltiesDueAfterFourthYear
32500000 USD
CY2021Q2 us-gaap Contractual Obligation
ContractualObligation
52397000 USD
CY2021Q2 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
8497000 USD
CY2021Q2 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
3800000 USD
CY2021Q2 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
3800000 USD
CY2021Q2 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
3800000 USD
CY2021Q2 ango Contractual Obligation To Be Paid After Year Four
ContractualObligationToBePaidAfterYearFour
32500000 USD
CY2021 us-gaap Revenues
Revenues
291010000 USD
CY2020 us-gaap Revenues
Revenues
264157000 USD
CY2019 us-gaap Revenues
Revenues
270634000 USD
CY2021 us-gaap Revenues
Revenues
291010000 USD
CY2020 us-gaap Revenues
Revenues
264157000 USD
CY2019 us-gaap Revenues
Revenues
270634000 USD
CY2021 ango Percentage Of International Sales To Net Sales
PercentageOfInternationalSalesToNetSales
0.19
CY2020 ango Percentage Of International Sales To Net Sales
PercentageOfInternationalSalesToNetSales
0.21
CY2019 ango Percentage Of International Sales To Net Sales
PercentageOfInternationalSalesToNetSales
0.20
CY2021Q2 ango Percentage Of Domestic Assets
PercentageOfDomesticAssets
0.99
CY2021 ango Acquisition Restructuring And Other Items Net
AcquisitionRestructuringAndOtherItemsNet
20232000 USD
CY2020 ango Acquisition Restructuring And Other Items Net
AcquisitionRestructuringAndOtherItemsNet
6014000 USD
CY2019 ango Acquisition Restructuring And Other Items Net
AcquisitionRestructuringAndOtherItemsNet
15127000 USD

Files In Submission

Name View Source Status
ango-20210531_g5.jpg Edgar Link pending
0001275187-21-000013-index-headers.html Edgar Link pending
0001275187-21-000013-index.html Edgar Link pending
0001275187-21-000013.txt Edgar Link pending
0001275187-21-000013-xbrl.zip Edgar Link pending
ango-20210531.htm Edgar Link pending
ango-20210531.xsd Edgar Link pending
ango-20210531_cal.xml Edgar Link unprocessable
ango-20210531_def.xml Edgar Link unprocessable
ango-20210531_g1.gif Edgar Link pending
ango-20210531_g2.jpg Edgar Link pending
ango-20210531_g3.jpg Edgar Link pending
ango-20210531_g4.jpg Edgar Link pending
ango-20210531_g6.jpg Edgar Link pending
ango-20210531_g7.jpg Edgar Link pending
ango-20210531_g8.jpg Edgar Link pending
ango-20210531_htm.xml Edgar Link completed
ango-20210531_lab.xml Edgar Link unprocessable
ango-20210531_pre.xml Edgar Link unprocessable
ex2105312021.htm Edgar Link pending
ex23angio2021consentofdelo.htm Edgar Link pending
ex3115312110-k.htm Edgar Link pending
ex3125312110-k.htm Edgar Link pending
ex3215312110-k.htm Edgar Link pending
ex3225312110-k.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending